Workflow
千亿私募，持仓大腾挪！
Shang Hai Zheng Quan Bao·2025-08-10 02:14

Core Viewpoint - Jinglin Asset has made significant adjustments to its portfolio in the second quarter, focusing on increasing positions in Nvidia and Manbang Group while liquidating holdings in Apple, Pfizer, Legend Biotech, and ZTO Express. The firm believes that the valuation recovery of Chinese assets may be at a midpoint, necessitating a focus on identifying new companies with strong business models and cash flows [1][11]. Group 1: Portfolio Adjustments - As of the end of Q2, Jinglin Asset held stocks in 28 companies in the US market, with a total market value of $2.874 billion [1][12]. - The top ten holdings include Meta, NetEase, Manbang Group, Pinduoduo, Futu Holdings, Qifu Technology, Nvidia, Beike, New Oriental, and Nebius Group [3][12]. - New additions to the top ten holdings are Nvidia and Nebius Group, while significant reductions were made in technology and pharmaceutical stocks [4][5]. Group 2: Specific Stock Movements - Jinglin Asset increased its stake in Nvidia, acquiring 630,440 shares after previously selling 37,800 shares in Q1, indicating a renewed confidence in the company's valuation and fundamentals [5]. - The firm completely exited positions in Apple and reduced holdings in several tech stocks, including a more than 90% reduction in Taiwan Semiconductor Manufacturing Company and significant cuts in Hesai Technology [9][12]. - In the healthcare sector, Jinglin Asset liquidated positions in Regeneron, Pfizer, and Legend Biotech, reflecting a cautious stance towards certain pharmaceutical stocks [9]. Group 3: Market Outlook - Jinglin Asset remains optimistic about Chinese assets, focusing on structural opportunities despite macroeconomic pressures. The firm emphasizes the importance of monitoring policy changes and believes that new investment opportunities will arise in emerging sectors [11]. - The firm identifies potential growth areas in new consumer trends, innovative pharmaceuticals, and hard technology innovations in China, suggesting that the recovery of Chinese asset valuations is ongoing [11].